tradingkey.logo

BRIEF-Oramed Announces Joint Venture To Develop And Commercialize Oral Insulin

ReutersFeb 11, 2025 2:17 PM

- Oramed Pharmaceuticals ORMP.O:

  • ORAMED ANNOUNCES TRANSFORMATIVE JOINT VENTURE TO ACCELERATE DEVELOPMENT AND COMMERCIALIZATION OF ORAL INSULIN

  • ORAMED PHARMACEUTICALS INC - ANNOUNCES JOINT VENTURE WITH HTIT TO FORM ORATECH

  • ORAMED PHARMACEUTICALS INC: HTIT TO INVEST $60 MILLION, ORAMED TO INVEST $15 MILLION INTO ORATECH

  • ORAMED PHARMACEUTICALS INC - NEW PHASE 3 TRIAL IN U.S. EXPECTED TO BEGIN THIS QUARTER

  • ORAMED PHARMACEUTICALS INC: ORAMED SHAREHOLDERS TO RECEIVE RIGHT TO A DIRECT STAKE IN ORATECH, EXPECTED TO GO PUBLIC ON NASDAQ

  • ORAMED PHARMACEUTICALS INC - ORATECH TO RECEIVE ROYALTY PAYMENTS FROM SALES OF ORAL INSULIN IN CHINA

Source text: ID:nPn3ZKqvVa

Further company coverage: ORMP.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI